To the Editor: We thank Wu et al. [1] for their thoughtful comments on our study, “Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population-Based Report From CYP-C” [2]. We wish to clarify the scope of the Cancer in Young People in Canada (CYP-C) registry and contextualize our findings. We agree that restricting data collection to grade 3 and 4 complications underestimates the overall toxicity burden.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Y. -C.
Contact Y. -C., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack